Cagnon, M.-E.; Curia, S.; Serindoux, J.; Cros, J.-M.; Ng, F.; Lopez-Noriega, A.
Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables. Pharmaceutics 2021, 13, 605.
https://doi.org/10.3390/pharmaceutics13050605
AMA Style
Cagnon M-E, Curia S, Serindoux J, Cros J-M, Ng F, Lopez-Noriega A.
Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables. Pharmaceutics. 2021; 13(5):605.
https://doi.org/10.3390/pharmaceutics13050605
Chicago/Turabian Style
Cagnon, Marie-Emérentienne, Silvio Curia, Juliette Serindoux, Jean-Manuel Cros, Feifei Ng, and Adolfo Lopez-Noriega.
2021. "Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables" Pharmaceutics 13, no. 5: 605.
https://doi.org/10.3390/pharmaceutics13050605
APA Style
Cagnon, M.-E., Curia, S., Serindoux, J., Cros, J.-M., Ng, F., & Lopez-Noriega, A.
(2021). Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables. Pharmaceutics, 13(5), 605.
https://doi.org/10.3390/pharmaceutics13050605